747
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluating the hepatoprotective, Ameliorative and Antioxidant Potentials of the Crude Aqueous Leafy Extracts of Mangifera Indica Plant Against Acute paracetamol-induced Hepatotoxicity in a Mouse Model

, ORCID Icon &
Article: FSO801 | Received 04 Oct 2021, Accepted 01 Jun 2022, Published online: 17 Jun 2022

References

  • NiknahadH , HeidariR , AlzuhairiAM , NajibiA. Mitochondrial dysfunction as a mechanism for pioglitazone-induced injury toward HepG2 cell line. Pharm. Sci.20, 169–174 (2015).
  • ChojkierM. Troglitazone and liver injury: in search of answers. Hepatology41, 237–246 (2005).
  • NozawaT , SugiuraS , NakajimaMet al.Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab. Disposition32, 291–294 (2004).
  • LarsonAM , PolsonJ , FontanaRJet al.Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology42, 1364–1372 (2005).
  • ChalasaniN , BjornssonE. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology138, 2246–2259 (2010).
  • IkedaT. Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone case. Drug Metab. Pharmacokinet.26, 60–70 (2011).
  • KohlroserJ , MathaiJ , ReichheldJ , BannerBF , BonkovskyHL. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events 229 reported to the United States Food and Drug Administration. Am. J. Gastroenterol.95, 272–276 (2000).
  • BuchweitzJP , GaneyPE , BursianSJ , RothRA. Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?J. Pharmacol. Exp. Ther.300, 460–467 (2002).
  • KedderisGL. Biochemical basis of hepatocellular injury. Toxicol. Pathol.24, 77–83 (1996).
  • MonshouwerM , WitkampRF , NijmeijerSMet al.Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P450 3A mRNA levels in pigs. Drug Metab. Dispos.23, 44–47 (1995).
  • SeemanP. The membrane actions of anesthetics and tranquilizers. Pharmacol. Rev.24, 583–655 (1972).
  • WallaceJL. Acetaminophen hepatotoxicity: no to the rescue. Br. J. Pharmacol.143, 1–2 (2004).
  • MasudaY. Learning toxicology from carbon tetrachloride-induced hepatotoxicity. Yakugaku Zasshi126, 885–899 (2006).
  • ShimizuS , AtsamiR , ItokawaK , IwasakiM , AokiTet al.Metabolism dependent hepatotoxicity of amodiaquine in glutathione-depleted mice. Arch. Toxicol.83, 701–707 (2009).
  • SarichTC , YoussefiM , ZhouT , AdamsSP , WallRAet al.Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Arch. Toxicol.70, 835–840 (1996).
  • LeeWM. Drug-induced hepatotoxicity. N. Engl. J. Med.349, 474–485 (2003).
  • MeisterA. Glutathione metabolism and its selective modification. J. Biol. Chem.263, 17205–17208 (1988).
  • ReubenA. Hy's law. Hepatol.39, 574–578 (2004).
  • NavarroVJ , SeniorJR. Drug-related hepatotoxicity. N. Engl. J. Med.354, 731–739 (2006).
  • TeschkeR. Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issues. Ann. Hepatol.8, 184–195 (2009).
  • BoverisA , RepettoMG , BustamanteJ , BoverisAD , ValdezLB. The concept of oxidative stress in pathology. ÁlvarezS, EvelsonP ( Eds). Free Radical Pathophysiology, 1–17 (2008).
  • BhragualDD , KumarN , GargVK , SharmaPK. Review on plants having hepatoprotective activity. J. Pharm. Res.3, 2077–2082 (2010).
  • Vishnu PriyaV , NivedaS , PratikshaG , GayathriR. A review of hepatoprotective natural products. Recent Res. Sci. Technol.2, 49–52 (2010).
  • DeshwalN , SharmaAK , SharmaP. Review on hepatoprotective plants. Int. J. Pharm. Sci. Rev. Res.7, 15–26 (2011).
  • ScartezziniP , SperoniE. Review on some plants of Indian traditional medicine with antioxidant activity. J. Ethnopharmacol.71, 23–43 (2000).
  • SaruthN , PimolpanP , RapepolB. Antioxidant and hepatoprotective activities of Thai mango seed kernel extract. Planta Med.75(10), 1118–1123 (2009).
  • PradhanSC , GirishC. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J. Med. Res.124, 491–504 (2006).
  • PitchaonM. Antioxidant capacity of extracts and fractions from mango (Mangifera indica Linn.) seed kernels. Int. Food Res. J.201, 523–528 (2014).
  • JoonaK , SowmiaC , DhanyaKP , DivyaMJ. Preliminary phytochemical investigation of Mangifera indica leaves and screening of antioxidant and anticancer activity. RJPBCS4(1), 1112–1118 (2013).
  • PrasadS , KalraN. Hepatoprotective effect of lupeal and mango pulp extract of carcinogen induced alteration in swiss albino mice. J. Food Res.51, 352–359 (2007).
  • LathaKP , LathaMS , VagdeviHM , VirupaxappaSB. Anti-inflammatory activity of Mangifera indica L. Var. Rasapuri root extracts. J. Chem. Pharm. Res.4(1), 333–336 (2012).
  • KhanMN , NizamiSS , KhanMA , AhmedZ. New saponins from Mangifera indica. J. Nat. Prod.56, 767–770 (1993).
  • DaviesD. In: Textbook of adverse drug reactions.Oxford University Press18–45 (1985).
  • BattistiV , MadersLD , BagatiniMDet al.Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin. Biochem.41, 511–518 (2008).
  • HamburgerM , HostettmannK. Bioactivity in plants: the link between phytochemistry and medicine. Phytochem30, 3864–3874 (1991).
  • HaslerCM , BlumbergJB. Symposium on phytochemicals: biochemistry and physiology. J. Nut.129, S756–S757 (1999).